Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute and chronic pericarditis: how to best manage your patients Pericarditis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by